Psychiatry and Heart Disease

Psychiatry and Heart Disease is a pioneering book connecting the heart and brain, from basic science to clinical management of conditions that affect millions of patients around the world. The interplay between psychiatric problems, particularly depression, and cardiovascular disease, with each increasing susceptibility to the other, has been established in recent years. This unique book features chapters co–authored by psychiatrists and cardiovascular specialists , combining their expertise to provide guidance on the best way to manage such patients, considering the patient as a whole, not the individual conditions. The book starts with the association between cardiovascular risk factors, heart diseases, and psychological distress. It then describes important psychiatric issues that arise in patients undergoing cardiac transplantation, following resuscitated sudden death, after implantation of defibrillator devices, and in patients with pulmonary hypertension. The second half of the book addresses the differences between symptoms of cardiovascular and psychological disorders, the management of the patient with bipolar disorder, the relationship of sleep with cardiovascular disease, and post traumatic stress syndrome. A common problem, cardiovascular manifestations of patients with panic and anxiety syndromes, is covered in exquisite detail. Lastly, the authors have offered interesting discussions on genetic susceptibility, psychosocial symptoms from medications and psychiatric drugs, and the contributions of exercise, fitness and smoking cessation. Each chapter contains basic information on the cardiovascular problem aimed at the psychiatrist and basic information on the psychiatric problems aimed at the cardiologists and primary care clinicians. The pathobiology of the interaction between psychological and cardiovascular disorders is reviewed within each chapter. The book is clinically oriented, including short vignettes, and summary points for quick review. Table of Contents List of Contributors, vii Foreword, xi Kim A. Eagle, MD Preface, xii Lawson Wulsin, MD, Michelle B. Riba, MD, MS, Melvyn Rubenfire, MD and Divy Ravindranath, MD, MS 1 The Interaction Between Psychologic Distress and Biobehavioral Processes in Cardiovascular Disease, 1 Willem J. Kop, PhD and John S. Gottdiener, MD 2 Depression and Cardiovascular Diseases, 18 Kevin B. Kerber, MD and Melvyn Rubenfire, MD 3 Depression, Anxiety, Anger, and Heart Failure, 34 Oliver G. Cameron, MD,PhD, Daniel Ehrmann and Bertram Pitt, MD 4 Cardiac Surgery, 49 Rima Styra, MD, Med, FRCPC, Christopher M. Feindel, MD and Marion E. McRae, RN, NP, MScN, CCRN–CSC–CMC, CCN, ACNP–BC 5 Cardiac Transplantation and Left Ventricular Assist Devices: Pre–Assessment and Post–Management, 62 Rachel Lipson Glick, MD, David Bradley S. Dyke, MD, Moira Kessler, BS, MD and Dayna J. LePlatte, MD 6 Psychiatric Aspects of Sudden Cardiac Arrest and Implantable Cardioverter–Defibrillators, 77 Divy Ravindranath, MD, MS and Frank Pelosi, MD 7 Pulmonary Arterial Hypertension: Psychosocial Implications and Treatment, 88 John M. Wryobeck, PhD and Melvyn Rubenfire, MD 8 Distinguishing Cardiac from Psychologic Somatic Symptoms, 99 Nicholas D. Giardino, PhD and Michael J. Shea, MD 9 Hypertrophic Cardiomopathy, 106 Moira Kessler, BS, MD, Sara Saberi, MD, Sharlene Day, MD, Tamara Gay, MD, Linda Baty, BSN and Edward Deneke, MD 10 Bipolar Disorder and Reducing Risk for Cardiovascular Disease, 116 Amy M. Kilbourne, PhD, MPH and David E. Goodrich, EdD 11 Sleep and Cardiovascular Disease, 135 Sanjaya Gupta, MD and J. Todd Arnedt, PhD 12 Posttraumatic Stress Disorder and Heart Disease, 153 Leonard A. Doerfler, PhD and John A. Paraskos, MD 13 Cardiovascular Manifestations of Panic and Anxiety, 165 Steven M. Schwartz, PhD, Oliver G. Cameron, MD, PhD and Melvyn Rubenfire, MD 14 Genetic Susceptibility and the Relationship between Cardiovascular Disease, Immunology, and Psychiatric Illness, 176 Sandra Villafuerte, PhD, Melvyn Rubenfire, MD and Ziad Kronfol, MD 15 Psychological Symptoms Associated with Cardiovascular Drugs; Cardiac Symptoms from Psychiatric Drugs; Drug Interactions, 194 Steven R. Erickson, Pharm D, Jolene R. Bostwick, Pharm D and Sally K. Guthrie, Pharm D 16 Exercise and Depression, 211 Barry A. Franklin, PhD, Justin E. Trivax, MD and Thomas E. Vanhecke, MD 17 Psychosocial Interventions: Meditation, 223 Elizabeth A.R. Robinson, PhD, MSW, MPH, Sandra M. Finkel, MPH and Elizabeth A. Jackson, MD, MPH 18 Smoking Cessation and Substance Use Modification in Cardiovascular Disease, 232 Gregory W. Dalack, MD and Elizabeth A. Jackson, MD, MPH Appendix A: Selected Screening Tools and Research Instruments, 241 Appendix B: Berlin Questionnaire (for sleep apnea), 247 Index, 249